U.S. Markets closed

Viking Therapeutics, Inc. (VKTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.53+0.24 (+3.29%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.02
52-Week Change 32.24%
S&P500 52-Week Change 3N/A
52 Week High 38.87
52 Week Low 33.26
50-Day Moving Average 37.13
200-Day Moving Average 36.41

Share Statistics

Avg Vol (3 month) 31.49M
Avg Vol (10 day) 31.46M
Shares Outstanding 572.76M
Float 56.05M
% Held by Insiders 110.98%
% Held by Institutions 156.67%
Shares Short (Jul 14, 2020) 49.96M
Short Ratio (Jul 14, 2020) 46.61
Short % of Float (Jul 14, 2020) 417.70%
Short % of Shares Outstanding (Jul 14, 2020) 413.70%
Shares Short (prior month Jun 14, 2020) 410.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-8.37%
Return on Equity (ttm)-11.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-32.44M
Diluted EPS (ttm)-0.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)263M
Total Cash Per Share (mrq)3.62
Total Debt (mrq)514k
Total Debt/Equity (mrq)0.20
Current Ratio (mrq)29.89
Book Value Per Share (mrq)3.60

Cash Flow Statement

Operating Cash Flow (ttm)-26.11M
Levered Free Cash Flow (ttm)-21.46M